Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

203
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
203
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

224
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
224
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

261
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
261
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

281
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
281
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

143
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
143
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

452
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
452

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis and Management of Acute and Chronic Lithium-Associated Nephrotoxicity.

Journal of the American Society of Nephrology : JASN·2026
Same author

Conventional cytotoxic chemotherapy-associated nephrotoxicity: consensus report of the 34th Acute Disease Quality Initiative (ADQI) Workgroup.

Kidney international·2026
Same author

Cancer therapy and the kidney.

Kidney international·2026
Same author

Outcomes of Femoral Neck System Procedures in a Major Trauma Centre.

Cureus·2026
Same author

Biology of drug-induced acute nephrotoxicity: focus on the tubulointerstitium.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2025
Same author

The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup.

Nature reviews. Nephrology·2025

Related Experiment Video

Updated: Dec 20, 2025

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

24.2K

NSAIDs in CKD: Are They Safe?

Megan Baker1, Mark A Perazella2

  • 1Department of Medicine, Yale University School of Medicine, New Haven, CT.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|June 2, 2020
PubMed
Summary

Managing pain in chronic kidney disease (CKD) is complex. This review examines the risks of nonsteroidal anti-inflammatory drugs (NSAIDs) in CKD patients, offering guidance for cautious use.

Keywords:
CKD progressionNonsteroidal anti-inflammatory drugs (NSAIDs)acute kidney injury (AKI)adverse effectsanalgesicchronic kidney disease (CKD)chronic paindrug safetyhyperkalemiahypervolemiahyponatremianephrotoxicitypain managementrenal dysfunctionreview

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.6K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.4K

Related Experiment Videos

Last Updated: Dec 20, 2025

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

24.2K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.6K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.4K

Area of Science:

  • Nephrology
  • Pharmacology
  • Pain Management

Background:

  • Pain management in chronic kidney disease (CKD) is challenging due to altered drug metabolism and limited safety data.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) are often avoided in CKD due to nephrotoxicity concerns, leading to increased opioid use.
  • Understanding NSAID risks in CKD is crucial given the known risks of alternative analgesics.

Purpose of the Study:

  • To characterize the risks associated with nonsteroidal anti-inflammatory drug (NSAID) use in patients with chronic kidney disease (CKD).
  • To provide recommendations for the safe and individualized use of NSAIDs in the CKD population.

Main Methods:

  • This study is a review of existing literature on NSAID use and nephrotoxicity in CKD patients.
  • Analysis of risk factors, comorbid conditions, and differing risks based on glomerular filtration rate levels.

Main Results:

  • NSAID use in CKD is associated with acute kidney injury, reduced glomerular filtration rate, electrolyte imbalances, and fluid overload.
  • The risk of NSAID-induced nephrotoxicity is influenced by comorbidities and the specific level of kidney function.
  • Individualized risk assessment is necessary due to varying risk factors and patient characteristics.

Conclusions:

  • NSAIDs pose significant nephrotoxic risks in CKD patients, including acute kidney injury and worsening renal function.
  • Risk stratification based on comorbidities, risk factors, and glomerular filtration rate is essential for safe NSAID prescribing.
  • Cautious, individualized NSAID use may be considered in CKD patients after thorough risk-benefit assessment.